Showing 491-500 of 7171 results for "".
The Dermatology & Aesthetics Mergers and Acquisitions Market
https://practicaldermatology.com/issues/practicaldermatology-com-march-2025/the-dermatology-aesthetics-mergers-and-acquisitions-market/33166/Over the past decade, the dermatology and aesthetics mergers and acquisitions (M&A) market has experienced notable trends that continue to shape its trajectory.Masterclasses in Dermatology: Updates on Vasculitis
https://practicaldermatology.com/programs/practical-dermatology/masterclasses-in-dermatology-updates-on-vasculitis/33018/Scott Elman, MD, a double board-certified internist and dermatologist at the University of Miami, outlines his talks at Masterclasses in Dermatology on the latest updates on vasculitis and on the importance of diagnosing dermatomyositis.Updates in Vulvar Dermatology
https://practicaldermatology.com/conferences/masterclasses-in-dermatology-2025/updates-in-vulvar-dermatology/33012/Melissa Mauskar, MD, an associate professor and director of the vulvar heatlh program at UT Southwestern Medical Center, talks about the importance of having dermatologists promote vulvar health and regular examination, while also working to reduce patient anxiety.Acne and Rosacea: Dr. Harper
https://practicaldermatology.com/programs/practical-dermatology/acne-and-rosacea-dr-harper/32686/Julie Harper, MD, summarizes her presentation during the "Update 2025: Acne and Rosacea" session at Maui Derm 2025, which focused on spironolactone, oral contraceptives, and topical clascoterone.Clinical Development of Emrosi for Rosacea
https://practicaldermatology.com/series/c-suite-chats/clinical-development-emrosi-rosacea/32379/Claude Maraoui, President and CEO of Journey Medical, discusses the clinical development program for Emrosi, which was recently approved by the FDA for inflammatory lesions of rosacea in adults.ISDPA: Dr. Lal on Therapeutic Updates
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-lal-therapeutic-updates/29149/Karan Lal, DO, discusses the latest therapeutic updates for atopic dermatitis and other conditions, including his strategies for utilizing dupilumab, at the Illinois Society of Dermatology Physician Assistants (ISDPA) Midwest Dermatology Conference 2024.Collagen in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/collagen-in-atopic-dermatitis/26997/Dr. Peter Lio and Kripa Ahuja, MS, take a closer look at a 2024 study by Szalus et al. highlighting the importance of collagen in the extracellular matrix, which could potentially serve as a therapeutic target for atopic dermatitis (AD).Noah Worcester 2024: Dr. Green and Dr. Weinstein on Medicare
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-green-and-dr-weinstein-medicare/24582/Noah Worcester 2024: Dr. Green and Dr. Weinstein on MedicareWhy It’s Critical to Distinguish Between Rosacea Subtypes for Best Results
https://practicaldermatology.com/conferences/maui-derm-2024/why-its-critical-to-distinguish-between-rosacea-subtypes-for-best-results/20245/In the Acne and Rosacea Updates symposium, Hilary Baldwin, MD, explained how she evaluates and treats rosacea with phenotypic therapies based on which aspects of the disease patients are most concerned about.PsA-5T-Ds: A New Psoriatic Arthritis Assessment Tool
https://practicaldermatology.com/topics/psoriasis/psa-5t-ds-a-new-psoriatic-arthritis-assessment-tool/20227/The PsA 5-Thermometer Scale Domains (PsA-5T-Ds) measures patient-reported pain, fatigue, physical function, skin problems, and depression. Here, Philip Mease, MD, discusses the validity of this tool in three Phase 3 studies of guselkumab as well as the role it could play in practice.